PT1359222E - Factor viii hibrido humano/suino - Google Patents
Factor viii hibrido humano/suinoInfo
- Publication number
- PT1359222E PT1359222E PT03075987T PT03075987T PT1359222E PT 1359222 E PT1359222 E PT 1359222E PT 03075987 T PT03075987 T PT 03075987T PT 03075987 T PT03075987 T PT 03075987T PT 1359222 E PT1359222 E PT 1359222E
- Authority
- PT
- Portugal
- Prior art keywords
- factor viii
- swine
- human hybrid
- viii human
- domain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/10—Factor VIII, AHF; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/864,004 US5364771A (en) | 1992-04-07 | 1992-04-07 | Hybrid human/porcine factor VIII |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1359222E true PT1359222E (pt) | 2006-07-31 |
Family
ID=25342308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT03075987T PT1359222E (pt) | 1992-04-07 | 1993-04-07 | Factor viii hibrido humano/suino |
Country Status (12)
Country | Link |
---|---|
US (2) | US5364771A (pt) |
EP (2) | EP0638088B1 (pt) |
JP (2) | JP3440097B2 (pt) |
AT (2) | ATE284963T1 (pt) |
AU (1) | AU682147B2 (pt) |
CA (1) | CA2133203C (pt) |
DE (2) | DE69333724T2 (pt) |
DK (2) | DK0638088T3 (pt) |
ES (2) | ES2235154T3 (pt) |
HK (1) | HK1058946A1 (pt) |
PT (1) | PT1359222E (pt) |
WO (1) | WO1993020093A1 (pt) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5663060A (en) * | 1992-04-07 | 1997-09-02 | Emory University | Hybrid human/animal factor VIII |
US6180371B1 (en) | 1996-06-26 | 2001-01-30 | Emory University | Modified factor VIII |
US5859204A (en) * | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
US5563045A (en) * | 1992-11-13 | 1996-10-08 | Genetics Institute, Inc. | Chimeric procoagulant proteins |
US5910481A (en) * | 1995-11-13 | 1999-06-08 | Immuno Ag | Hybrid proteins with modified activity |
US6458563B1 (en) * | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
US7560107B2 (en) | 1996-06-26 | 2009-07-14 | Emory University | Modified factor VIII |
CZ20011021A3 (cs) | 1998-09-21 | 2001-10-17 | Genetics Institute, Inc. | Způsoby tlumení imunitní odpovědi na terapeutické proteiny |
DK1129186T4 (da) * | 1998-11-10 | 2017-02-06 | Stichting Sanquin Bloedvoorziening | Et faktor VIII-polypeptid med faktor VIII:C-aktivitet |
JP2005518181A (ja) * | 2001-01-12 | 2005-06-23 | ジ・アメリカン・ナショナル・レッド・クロス | 第viii因子のヘパラン硫酸プロテオグリカン仲介性クリアランスを低下させるための方法および組成物 |
ES2331909T3 (es) | 2001-06-14 | 2010-01-20 | The Scripps Research Institute | Factor viii estabilizado con enlaces disulfuro modificados geneticamente. |
JP2005509409A (ja) * | 2001-08-08 | 2005-04-14 | ジェンザイム・コーポレーション | 糖尿病および他の血糖疾患の治療方法 |
US20040143104A1 (en) * | 2001-08-08 | 2004-07-22 | Wadsworth Samuel C. | Methods of treating diabetes and other blood sugar disorders |
CA2461443C (en) | 2001-10-05 | 2011-07-12 | Emory University | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
MXPA04005079A (es) * | 2001-11-30 | 2004-08-19 | Univ Emory | Variantes del dominio c2 del factor viii. |
WO2005046583A2 (en) * | 2003-10-30 | 2005-05-26 | Emory University | Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
US7211559B2 (en) | 2003-10-31 | 2007-05-01 | University Of Maryland, Baltimore | Factor VIII compositions and methods |
US20050107318A1 (en) * | 2003-11-17 | 2005-05-19 | Samuel Wadsworth | Methods of treating diabetes and other blood sugar disorders |
PL1750733T3 (pl) | 2004-05-03 | 2014-05-30 | Univ Emory | Sposób podawania świńskiego czynnika krzepnięcia VIII pozbawionego domeny B |
WO2006029258A2 (en) | 2004-09-07 | 2006-03-16 | Archemix Corp. | Aptamer medicinal chemistry |
BRPI0514984A (pt) | 2004-09-07 | 2008-07-01 | Archemix Corp | aptámeros para o fator de von willebrand e sua utilização como terapêuticos para doença trombótica |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
US20060080848A1 (en) * | 2004-10-19 | 2006-04-20 | Lace Charles R | Wheel blade sight |
US20100256062A1 (en) | 2004-12-06 | 2010-10-07 | Howard Tommy E | Allelic Variants of Human Factor VIII |
CA2604299A1 (en) * | 2005-04-14 | 2006-10-19 | Csl Behring Gmbh | Modified coagulation factor viii with enhanced stability and its derivates |
EP1816201A1 (en) * | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
PL2007885T3 (pl) * | 2006-04-11 | 2010-12-31 | Csl Behring Gmbh | Sposób zwiększania odzysku peptydów terapeutycznych in vivo |
US7939632B2 (en) * | 2006-06-14 | 2011-05-10 | Csl Behring Gmbh | Proteolytically cleavable fusion proteins with high molar specific activity |
EP1935430A1 (en) * | 2006-12-22 | 2008-06-25 | CSL Behring GmbH | Modified coagulation factors with prolonged in vivo half-life |
WO2008077616A1 (en) * | 2006-12-22 | 2008-07-03 | Csl Behring Gmbh | Modified coagulation factors with prolonged in vivo half-life |
FR2913020B1 (fr) * | 2007-02-23 | 2012-11-23 | Biomethodes | Nouveaux facteurs viii pour le traitement des hemophiles de type a |
KR101648734B1 (ko) * | 2008-06-24 | 2016-08-18 | 체에스엘 베링 게엠베하 | 연장된 생체내 반감기를 갖는 인자 viii, 폰 빌레브란트 인자 또는 이들의 복합체 |
AU2010290077C1 (en) | 2009-08-24 | 2015-12-03 | Bioverativ Therapeutics Inc. | Coagulation factor IX compositions and methods of making and using same |
JP5876416B2 (ja) | 2009-11-13 | 2016-03-02 | グリフオルス・セラピユーテイクス・インコーポレーテツドGrifols Therapeutics,Inc. | フォンウィルブランド因子(vWF)含有調製品並びにこれに関連する方法、キット及び使用 |
ES2880038T3 (es) | 2009-12-06 | 2021-11-23 | Bioverativ Therapeutics Inc | Polipéptidos quiméricos e híbridos de factor VIII-Fc, y métodos de uso de los mismos |
BR112012017483A2 (pt) * | 2010-01-14 | 2019-09-24 | Haplomics Inc | previsão e redução de aloimunogenicidade de terapêuticos de proteína |
WO2011127426A1 (en) * | 2010-04-08 | 2011-10-13 | Baxter International Inc. | Methods for modeling protein stability |
WO2012006623A1 (en) | 2010-07-09 | 2012-01-12 | Biogen Idec Hemophilia Inc. | Systems for factor viii processing and methods thereof |
EP2635297B1 (en) | 2010-11-05 | 2019-02-27 | Baxalta GmbH | A new variant of antihemophilic factor viii having increased specific activity |
PL2717898T3 (pl) | 2011-06-10 | 2019-06-28 | Bioverativ Therapeutics Inc. | Związki o działaniu prokoagulacyjnym i sposoby ich stosowania |
RS58578B1 (sr) | 2011-07-08 | 2019-05-31 | Bioverativ Therapeutics Inc | Faktor viii himernih i hibridnih polipeptida i postupci za njihovu upotrebu |
US10656167B2 (en) | 2011-07-25 | 2020-05-19 | Bioverativ Therapeutics Inc. | Assays to monitor bleeding disorders |
EP3453402B1 (en) | 2012-01-12 | 2021-07-21 | Bioverativ Therapeutics Inc. | Reducing immunogenicity against factor viii in individuals undergoing factor viii therapy |
BR112014017165B1 (pt) | 2012-01-12 | 2023-05-02 | Bioverativ Therapeutics Inc | Proteína quimérica compreendendo uma proteína de fator viii, composição farmacêutica, e seus usos |
ES2771208T3 (es) | 2012-02-15 | 2020-07-06 | Bioverativ Therapeutics Inc | Composiciones de factor VIII y métodos de preparación y uso de las mismas |
EP3549953A1 (en) | 2012-02-15 | 2019-10-09 | Bioverativ Therapeutics Inc. | Recombinant factor viii proteins |
CN110054699A (zh) | 2012-07-11 | 2019-07-26 | 比奥贝拉蒂治疗公司 | 具有xten和血管性血友病因子蛋白的因子viii复合物、及其用途 |
EP2877202A4 (en) | 2012-07-25 | 2016-06-01 | Biogen Ma Inc | BLOOD FACTOR MONITORING TEST AND USES THEREOF |
EP2908847B1 (en) | 2012-10-18 | 2022-03-30 | Bioverativ Therapeutics Inc. | Methods of using a fixed dose of a clotting factor |
WO2014070953A1 (en) | 2012-10-30 | 2014-05-08 | Biogen Idec Ma Inc. | Methods of Using FVIII Polypeptide |
US10272163B2 (en) | 2012-12-07 | 2019-04-30 | The Regents Of The University Of California | Factor VIII mutation repair and tolerance induction |
LT2968477T (lt) | 2013-03-15 | 2020-03-10 | Bioverativ Therapeutics Inc. | Faktoriaus viii polipeptido kompozicijos |
EP2796145B1 (en) | 2013-04-22 | 2017-11-01 | CSL Ltd. | A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge |
US20160102133A1 (en) | 2013-06-24 | 2016-04-14 | Weidong Xiao | Mutant factor viii compositions and methods |
CN105392495A (zh) | 2013-06-28 | 2016-03-09 | 比奥根Ma公司 | 具有xten的凝血酶可裂解连接子和其用途 |
US10947269B2 (en) | 2013-08-08 | 2021-03-16 | Bioverativ Therapeutics Inc. | Purification of chimeric FVIII molecules |
WO2015023891A2 (en) | 2013-08-14 | 2015-02-19 | Biogen Idec Ma Inc. | Factor viii-xten fusions and uses thereof |
EP3065769A4 (en) | 2013-11-08 | 2017-05-31 | Biogen MA Inc. | Procoagulant fusion compound |
ES2967617T3 (es) | 2013-12-06 | 2024-05-03 | Bioverativ Therapeutics Inc | Herramientas de farmacocinética poblacional y sus usos |
CN106456718A (zh) | 2014-01-10 | 2017-02-22 | 比奥根Ma公司 | 因子viii嵌合蛋白及其用途 |
EA201890423A1 (ru) | 2015-08-03 | 2018-07-31 | Биовератив Терапьютикс Инк. | Слитые белки фактора ix, способы их получения и применения |
JP2021523878A (ja) | 2018-05-18 | 2021-09-09 | バイオベラティブ セラピューティクス インコーポレイテッド | 血友病aを処置する方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE32011E (en) * | 1981-12-14 | 1985-10-22 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
US4757006A (en) * | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4970300A (en) * | 1985-02-01 | 1990-11-13 | New York University | Modified factor VIII |
US4868112A (en) * | 1985-04-12 | 1989-09-19 | Genetics Institute, Inc. | Novel procoagulant proteins |
US4980456A (en) * | 1987-04-06 | 1990-12-25 | Scripps Clinic And Research Foundation | Recombinant factor VIIIC derived fragments |
US5004803A (en) * | 1988-11-14 | 1991-04-02 | Genetics Institute, Inc. | Production of procoagulant proteins |
SE465222C5 (sv) * | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
US5246850A (en) * | 1990-07-31 | 1993-09-21 | Genentech, Inc. | DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells |
SE468050C (sv) * | 1991-03-15 | 1998-04-27 | Pharmacia & Upjohn Ab | Rekombinant derivat av human faktor VIII |
US5563045A (en) * | 1992-11-13 | 1996-10-08 | Genetics Institute, Inc. | Chimeric procoagulant proteins |
-
1992
- 1992-04-07 US US07/864,004 patent/US5364771A/en not_active Expired - Lifetime
-
1993
- 1993-04-07 WO PCT/US1993/003275 patent/WO1993020093A1/en active IP Right Grant
- 1993-04-07 ES ES93912141T patent/ES2235154T3/es not_active Expired - Lifetime
- 1993-04-07 ES ES03075987T patent/ES2261866T3/es not_active Expired - Lifetime
- 1993-04-07 JP JP51778293A patent/JP3440097B2/ja not_active Expired - Fee Related
- 1993-04-07 AT AT93912141T patent/ATE284963T1/de not_active IP Right Cessation
- 1993-04-07 DK DK93912141T patent/DK0638088T3/da active
- 1993-04-07 AU AU42799/93A patent/AU682147B2/en not_active Ceased
- 1993-04-07 AT AT03075987T patent/ATE322544T1/de not_active IP Right Cessation
- 1993-04-07 PT PT03075987T patent/PT1359222E/pt unknown
- 1993-04-07 CA CA002133203A patent/CA2133203C/en not_active Expired - Fee Related
- 1993-04-07 EP EP93912141A patent/EP0638088B1/en not_active Expired - Lifetime
- 1993-04-07 DE DE69333724T patent/DE69333724T2/de not_active Expired - Fee Related
- 1993-04-07 DE DE69334003T patent/DE69334003T2/de not_active Revoked
- 1993-04-07 DK DK03075987T patent/DK1359222T3/da active
- 1993-04-07 EP EP03075987A patent/EP1359222B1/en not_active Revoked
-
1994
- 1994-05-31 US US08/251,937 patent/US5583209A/en not_active Expired - Lifetime
-
2002
- 2002-10-23 JP JP2002308930A patent/JP3495365B2/ja not_active Expired - Fee Related
-
2004
- 2004-03-08 HK HK04101701A patent/HK1058946A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0638088B1 (en) | 2004-12-15 |
HK1058946A1 (en) | 2004-06-11 |
JP2003174876A (ja) | 2003-06-24 |
EP1359222A3 (en) | 2003-11-19 |
EP1359222B1 (en) | 2006-04-05 |
JP3495365B2 (ja) | 2004-02-09 |
ES2235154T3 (es) | 2005-07-01 |
DE69334003D1 (de) | 2006-05-18 |
US5364771A (en) | 1994-11-15 |
ATE322544T1 (de) | 2006-04-15 |
ES2261866T3 (es) | 2006-11-16 |
US5583209A (en) | 1996-12-10 |
EP0638088A1 (en) | 1995-02-15 |
EP1359222A2 (en) | 2003-11-05 |
DE69333724D1 (de) | 2005-01-20 |
CA2133203A1 (en) | 1993-10-14 |
JP3440097B2 (ja) | 2003-08-25 |
DK0638088T3 (da) | 2005-04-25 |
ATE284963T1 (de) | 2005-01-15 |
DK1359222T3 (da) | 2006-06-19 |
WO1993020093A1 (en) | 1993-10-14 |
JPH07508404A (ja) | 1995-09-21 |
EP0638088A4 (en) | 1996-06-26 |
DE69334003T2 (de) | 2007-01-25 |
DE69333724T2 (de) | 2005-11-10 |
AU682147B2 (en) | 1997-09-25 |
CA2133203C (en) | 2002-07-02 |
AU4279993A (en) | 1993-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1359222E (pt) | Factor viii hibrido humano/suino | |
DE3879543D1 (de) | Integriertes hochspannungserzeugungssystem. | |
DE69029180D1 (de) | Transistor mit Spannungsbegrenzungsanordnung | |
DE58901877D1 (de) | Elektrische zahnbuerste. | |
DE69324737T2 (de) | Selbstklebender Silikonkautschuk mit vermindertem Druckverformungsrest | |
DE3778438D1 (de) | Referenzspannung fuer transistorkonstantstromquelle. | |
DE69404840D1 (de) | Hybridzentralelektrik | |
NO921364D0 (no) | Hybridpolypeptid | |
DE68910428D1 (de) | Spannungs-/Stromwandler. | |
NL194688B (nl) | Instelspanningsbron. | |
DE3870803D1 (de) | Ozonerzeuger. | |
DE69127849D1 (de) | Bipolarer Transistor | |
DE3786778D1 (de) | Spannungsvergleichsschaltung. | |
DE68915894D1 (de) | Spannungs-/Stromwandler. | |
DE69419331D1 (de) | Dielektrisch isolierter bipolarer Transistor | |
DE69115157D1 (de) | Siloxankautschukzusammensetzung mit hoher Festigkeit. | |
DE69203169D1 (de) | Konstantstromquelle. | |
DE69315214T2 (de) | Elektrische zahnbürste | |
DE59105190D1 (de) | Elektrische zahnbürste. | |
DE59002341D1 (de) | Praezisions-referenzspannungsquelle. | |
ATE85725T1 (de) | Hochspannungsspannungswandler. | |
DE68910171D1 (de) | Flacher Spannungstransformator. | |
DE3886744D1 (de) | Spannungsquellen. | |
ITMI942213A0 (it) | Sorgente di corrente costante | |
DE69004117D1 (de) | Elektrische Lokomotive. |